THURSDAY, Sept. 2, 2021 (HealthDay News) — The prescribing, dispensing and use of ivermectin to prevent or treat COVID-19 outside of clinical trials must end immediately, the American Medical Association, American Pharmacists Association and American Society of Health-System Pharmacists say. The drug has U.S. Food and Drug Administration approval toContinue Reading

THURSDAY, Sept. 2, 2021 (HealthDay News) — Purdue Pharma was dissolved on Wednesday and the Sackler family will pay $4.5 billion under a bankruptcy settlement that will end thousands of lawsuits brought against the company over the United States’ opioid crisis. Purdue was the maker of the highly addictive painkillerContinue Reading

THURSDAY, Sept. 2, 2021 (HealthDay News) — As doctors around the world come up against severe cases of COVID-19, some positive news has emerged: New research shows the rheumatoid arthritis drug baricitinib may help reduce hospitalized COVID patients’ risk of death. Current standard-of-care medications aren’t enough, said study co-author Dr.Continue Reading

THURSDAY, Sept. 2, 2021 (HealthDay News) — If you’re vaccinated against COVID-19, you may still get infected — but the odds you’ll need hospitalization are reduced by about two-thirds compared to unvaccinated people, a new study reveals. Vaccination also greatly increases the chances that COVID-19 infection will be asymptomatic andContinue Reading

WEDNESDAY, Sept. 1, 2021 (HealthDay News) — A four-in-one pill containing “ultra-low doses” of different medications can provide better blood pressure control than standard drug treatment, a new clinical trial from Australia shows. About 80% of people given the “quadpill” achieved a healthy blood pressure of 140/90 within three monthsContinue Reading